Patients in phase one cancer drug trials often have metastatic disease and have progressed through all standard treatments, with safety as the primary goal.

“these are going to be patients with cancer if this is a drug that's being sought as a treatment for colon cancer these are going to be patients that all have colon cancer they're often going to be patients who have progressed through all other standard treatments”